Clinical Trial Update: Study of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Japanese Participants With Chronic Hepatitis C (MK-5172-058) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update of grazoprevir and elbasvir in Japanese participants with chronic hepatitis C has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Elbasvir (elbasvir)
• Grazoprevir (grazoprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-10-11